Archived articles

Drug prices

Merck CEO Robert M. Davis
Health Policy Forum
Hopkins to host conversation with Merck CEO Robert Davis
Published Sept 27, 2021
Davis, who leads one of the world's largest pharmaceutical companies, will discuss the COVID-19 pandemic and drug affordability on Oct. 4
Manufacturer's rendering of Aduhelm packaging
Q+A
Insights on FDA's controversial approval of Alzheimer's drug
Published June 21, 2021
Supriya Munshaw, an expert in drug commercialization, discusses what factors went into the FDA approval of aducanumab, a drug known by the brand name Aduhelm
Prescription bottles
Health policy
Study investigates effects of drug coupons and vouchers
Published March 30, 2021
Believed to be the largest study of its kind, it finds that only a slim portion of pharmaceuticals are covered by coupons and vouchers, and the offsets are not targeted to patients who likely need them most
Illustration of pills erupting from prescription bottle
Health policy
Requests for brand name prescription drugs cost Medicare additional $1.7B in 2017
Published March 4, 2021
Opting for generic over brand name prescription drugs would save hundreds of millions a year, study finds